Citation: K. Brune et A. Neubert, Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a pharmacologist's perspective, CLIN EXP RH, 19(6), 2001, pp. S51-S57
Authors:
Muller, T
Vos, A
Selhorst, T
Stiebling, U
Tackmann, K
Schuster, P
Neubert, A
Conraths, FJ
Schluter, H
Citation: T. Muller et al., Is it possible to orally vaccinate juvenile red foxes against rabies in spring campaigns?, J WILDL DIS, 37(4), 2001, pp. 791-797
Authors:
Vos, A
Neubert, A
Pommerening, E
Muller, T
Dohner, L
Neubert, L
Hughes, K
Citation: A. Vos et al., Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration, J GEN VIROL, 82, 2001, pp. 2191-2197
Authors:
Vos, A
Neubert, A
Aylan, O
Schuster, P
Pommerening, E
Muller, T
Chivatsi, DC
Citation: A. Vos et al., An update on safety studies of SAD B19 rabies virus vaccine in target and non-target species, EPIDEM INFE, 123(1), 1999, pp. 165-175
Citation: H. Bruchhaus et al., Problems in the evaluation of prehistoric burial finds (Anthropology and archaeology), ARCHAOL NAC, 4(1), 1999, pp. 89-100